Connection

David Klonoff to Insulin Aspart

Back to Details
This is a "connection" page, showing publications David Klonoff has written about Insulin Aspart.
David Klonoff
Connection Strength
0.796
Insulin Aspart
  1. A randomized, multicentre trial evaluating the efficacy and safety of fast-acting insulin aspart in continuous subcutaneous insulin infusion in adults with type 1 diabetes (onset 5). Diabetes Obes Metab. 2019 04; 21(4):961-967.
    View in: PubMed
    Score: 0.796
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.